Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DMP
San Francisco, California, United Statesdmppharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
DMP is a biotechnology company focused on the development of novel therapeutic agents for oncology and cardiovascular diseases. The company leverages its expertise in drug metabolism and pharmacokinetics to optimize the delivery and efficacy of its pipeline candidates. DMP's lead programs include small molecule inhibitors and monoclonal antibodies targeting key pathways in tumor growth and vascular health. With several candidates in mid-stage clinical trials, DMP aims to address significant unmet medical needs through innovative drug design and rigorous clinical evaluation.
- Therapeutic areas
- CardiovascularOncology
- Modalities
- Small moleculeMonoclonal antibody
- Industry
- Biotech
02
Partnerships
Beyond the preview
Go deeper on DMP.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DMP.